Cargando…

Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema

PURPOSE: Retinal function beyond foveal vision is not routinely examined in the clinical screening and management of diabetic retinopathy although growing evidence suggests it may precede structural changes. In this study we compare optical coherence tomography (OCT) based macular structure with fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabeti, Faran, Rai, Bhim B., van Kleef, Josh P., Rohan, Emilie M. F., Carle, Corinne F., Barry, Richard C., Essex, Rohan W., Nolan, Christopher J., Maddess, Ted
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270604/
https://www.ncbi.nlm.nih.gov/pubmed/37319294
http://dx.doi.org/10.1371/journal.pone.0287319
_version_ 1785059349434990592
author Sabeti, Faran
Rai, Bhim B.
van Kleef, Josh P.
Rohan, Emilie M. F.
Carle, Corinne F.
Barry, Richard C.
Essex, Rohan W.
Nolan, Christopher J.
Maddess, Ted
author_facet Sabeti, Faran
Rai, Bhim B.
van Kleef, Josh P.
Rohan, Emilie M. F.
Carle, Corinne F.
Barry, Richard C.
Essex, Rohan W.
Nolan, Christopher J.
Maddess, Ted
author_sort Sabeti, Faran
collection PubMed
description PURPOSE: Retinal function beyond foveal vision is not routinely examined in the clinical screening and management of diabetic retinopathy although growing evidence suggests it may precede structural changes. In this study we compare optical coherence tomography (OCT) based macular structure with function measured objectively with the ObjectiveFIELD Analyzer (OFA), and with Matrix perimetry. We did that longitudinally in Type 2 diabetes (T2D) patients with mild Diabetic Macular Oedema (DMO) with good vision and a similar number of T2D patients without DMO, to evaluate changes in retinal function more peripherally over the natural course of retinopathy. METHODS: Both eyes of 16 T2D patients (65.0 ± 10.1, 10 females), 10 with baseline DMO, were followed for up longitudinally for 27 months providing 94 data sets. Vasculopathy was assessed by fundus photography. Retinopathy was graded using to Early Treatment of Diabetic Retinopathy Study (ETDRS) guidelines. Posterior-pole OCT quantified a 64-region/eye thickness grid. Retinal function was measured with 10–2 Matrix perimetry, and the FDA-cleared OFA. Two multifocal pupillographic objective perimetry (mfPOP) variants presented 44 stimuli/eye within either the central 30° or 60° of the visual field, providing sensitivities and delays for each test-region. OCT, Matrix and 30° OFA data were mapped to a common 44 region/eye grid allowing change over time to be compared at the same retinal regions. RESULTS: In eyes that presented with DMO at baseline, mean retinal thickness reduced from 237 ± 25 μm to 234.2 ± 26.7 μm, while the initially non-DMO eyes significantly increased their mean thickness from 250.7 ± 24.4 μm to 255.7 ± 20.6 μm (both p<0.05). Eyes that reduced in retinal thickness over time recovered to more normal OFA sensitivities and delays (all p<0.021). Matrix perimetry quantified fewer regions that changed significantly over the 27 months, mostly presenting in the central 8 degrees. CONCLUSIONS: Changes in retinal function measured by OFA possibly offer greater power to monitor DMO over time than Matrix perimetry data.
format Online
Article
Text
id pubmed-10270604
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-102706042023-06-16 Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema Sabeti, Faran Rai, Bhim B. van Kleef, Josh P. Rohan, Emilie M. F. Carle, Corinne F. Barry, Richard C. Essex, Rohan W. Nolan, Christopher J. Maddess, Ted PLoS One Research Article PURPOSE: Retinal function beyond foveal vision is not routinely examined in the clinical screening and management of diabetic retinopathy although growing evidence suggests it may precede structural changes. In this study we compare optical coherence tomography (OCT) based macular structure with function measured objectively with the ObjectiveFIELD Analyzer (OFA), and with Matrix perimetry. We did that longitudinally in Type 2 diabetes (T2D) patients with mild Diabetic Macular Oedema (DMO) with good vision and a similar number of T2D patients without DMO, to evaluate changes in retinal function more peripherally over the natural course of retinopathy. METHODS: Both eyes of 16 T2D patients (65.0 ± 10.1, 10 females), 10 with baseline DMO, were followed for up longitudinally for 27 months providing 94 data sets. Vasculopathy was assessed by fundus photography. Retinopathy was graded using to Early Treatment of Diabetic Retinopathy Study (ETDRS) guidelines. Posterior-pole OCT quantified a 64-region/eye thickness grid. Retinal function was measured with 10–2 Matrix perimetry, and the FDA-cleared OFA. Two multifocal pupillographic objective perimetry (mfPOP) variants presented 44 stimuli/eye within either the central 30° or 60° of the visual field, providing sensitivities and delays for each test-region. OCT, Matrix and 30° OFA data were mapped to a common 44 region/eye grid allowing change over time to be compared at the same retinal regions. RESULTS: In eyes that presented with DMO at baseline, mean retinal thickness reduced from 237 ± 25 μm to 234.2 ± 26.7 μm, while the initially non-DMO eyes significantly increased their mean thickness from 250.7 ± 24.4 μm to 255.7 ± 20.6 μm (both p<0.05). Eyes that reduced in retinal thickness over time recovered to more normal OFA sensitivities and delays (all p<0.021). Matrix perimetry quantified fewer regions that changed significantly over the 27 months, mostly presenting in the central 8 degrees. CONCLUSIONS: Changes in retinal function measured by OFA possibly offer greater power to monitor DMO over time than Matrix perimetry data. Public Library of Science 2023-06-15 /pmc/articles/PMC10270604/ /pubmed/37319294 http://dx.doi.org/10.1371/journal.pone.0287319 Text en © 2023 Sabeti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sabeti, Faran
Rai, Bhim B.
van Kleef, Josh P.
Rohan, Emilie M. F.
Carle, Corinne F.
Barry, Richard C.
Essex, Rohan W.
Nolan, Christopher J.
Maddess, Ted
Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema
title Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema
title_full Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema
title_fullStr Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema
title_full_unstemmed Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema
title_short Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema
title_sort objective perimetry identifies regional functional progression and recovery in mild diabetic macular oedema
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270604/
https://www.ncbi.nlm.nih.gov/pubmed/37319294
http://dx.doi.org/10.1371/journal.pone.0287319
work_keys_str_mv AT sabetifaran objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema
AT raibhimb objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema
AT vankleefjoshp objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema
AT rohanemiliemf objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema
AT carlecorinnef objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema
AT barryrichardc objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema
AT essexrohanw objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema
AT nolanchristopherj objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema
AT maddessted objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema